Quarterly ResultJul 22, 2026, 04:22 PM
Medpace Q2 Revenue $707.3M, Net Income $121.4M; Raises 2026 Guidance
AI Summary
Medpace Holdings, Inc. reported strong second quarter 2026 financial results, with revenue increasing 17.2% to $707.3 million and GAAP net income growing 34.4% to $121.4 million. The company also announced net new business awards of $795.7 million, resulting in a healthy book-to-bill ratio of 1.13x. Medpace provided an optimistic full-year 2026 guidance, forecasting revenue between $2.805 billion and $2.885 billion and diluted EPS between $17.25 and $17.95.
Key Highlights
- Q2 2026 revenue increased 17.2% to $707.3 million.
- Q2 2026 GAAP net income rose 34.4% to $121.4 million, or $4.25 per diluted share.
- Net new business awards were $795.7 million, with a net book-to-bill ratio of 1.13x.
- EBITDA for Q2 2026 increased 17.6% to $153.4 million.
- Repurchased 705,616 shares for $294.7 million in Q2 2026.
- Forecasts 2026 revenue between $2.805 billion and $2.885 billion.
- Projects 2026 GAAP net income from $494.0 million to $514.0 million.
- Anticipates 2026 diluted EPS in the range of $17.25 to $17.95.
Price Impact
More from MEDP